Thus, FAP(hF1) UCAR T-cell treatment should create a long-lasting CAF-depleted tumor milieu, allowing a window for reconstitution of the endogenous immune system and subsequent TIL activity in this CAF-depleted state. Here, FAP is linked to neoplasm.